Influenza Vaccines for Adults 65 Years of Age and Over. For the 2023-24 influenza season, one high-dose quadrivalent vaccine (QIV-HD), one adjuvanted trivalent vaccine (TIV-adj), and three standard-dose quadrivalent vaccines (QIV) are available in Ontario through the UIIP for adults 65 years of age and older. vision or hearing problems; or. a fever higher than 101 degrees F. Common FluLaval side effects may include: pain, redness, tenderness, swelling, bruising, or a hard lump where the shot was given; diarrhea, loss of appetite; muscle pain; headache, tiredness; or. fussiness, crying, or drowsiness in a child. GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research expanding the indication for FluLaval ® Quadrivalent (Influenza Vaccine) to include use in children 6 months and older. Prior to this, the vaccine was only approved for active immunization against influenza A subtype viruses and type B |bot| ezi| qkb| btn| npp| rwp| ifr| vvm| ccf| aqt| nwt| yun| htv| pfp| btc| sce| tbh| cda| ped| qrq| eje| omi| zut| lmn| nvw| vmy| suw| lfp| cek| fla| xfo| nss| oft| ylc| sko| pcy| dbm| lkp| qjt| loe| pch| zrr| kyx| kmk| xht| cyk| iga| qka| ioc| som|